全文获取类型
收费全文 | 18954篇 |
免费 | 123篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 384篇 |
儿科学 | 437篇 |
妇产科学 | 817篇 |
基础医学 | 1861篇 |
口腔科学 | 1089篇 |
临床医学 | 2092篇 |
内科学 | 3867篇 |
皮肤病学 | 273篇 |
神经病学 | 1079篇 |
特种医学 | 415篇 |
外科学 | 3092篇 |
综合类 | 473篇 |
预防医学 | 1009篇 |
眼科学 | 632篇 |
药学 | 705篇 |
3篇 | |
中国医学 | 87篇 |
肿瘤学 | 783篇 |
出版年
2023年 | 37篇 |
2022年 | 169篇 |
2021年 | 314篇 |
2020年 | 112篇 |
2019年 | 8420篇 |
2018年 | 5095篇 |
2017年 | 1834篇 |
2016年 | 84篇 |
2015年 | 75篇 |
2014年 | 190篇 |
2013年 | 218篇 |
2012年 | 167篇 |
2011年 | 194篇 |
2010年 | 173篇 |
2009年 | 146篇 |
2008年 | 158篇 |
2007年 | 110篇 |
2006年 | 142篇 |
2005年 | 143篇 |
2004年 | 93篇 |
2003年 | 74篇 |
2002年 | 61篇 |
2001年 | 40篇 |
2000年 | 34篇 |
1999年 | 34篇 |
1998年 | 17篇 |
1997年 | 26篇 |
1996年 | 12篇 |
1995年 | 24篇 |
1994年 | 19篇 |
1993年 | 7篇 |
1991年 | 10篇 |
1990年 | 6篇 |
1989年 | 5篇 |
1988年 | 7篇 |
1987年 | 10篇 |
1986年 | 10篇 |
1985年 | 84篇 |
1984年 | 98篇 |
1983年 | 70篇 |
1982年 | 88篇 |
1981年 | 69篇 |
1980年 | 80篇 |
1979年 | 67篇 |
1978年 | 58篇 |
1977年 | 46篇 |
1976年 | 39篇 |
1975年 | 46篇 |
1974年 | 42篇 |
1973年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 16 毫秒
1.
2.
3.
4.
5.
Yuan Tian Gui-E Liu Wen-Jun Zhao Yuan-Yuan Peng ShuangMing Song Lei Li 《中华创伤杂志(英文版)》2019,22(1):21-23
Trauma is one of the leading causes of death worldwide. It is an urgent task to strengthen the trauma care and prevent the complications. In 2018, Chinese Journal of Traumatology reported a series of trauma-related articles of which the contents include pre-hospital care, in-hospital care and complication prevention, et al, aiming to improve the treatment levels, decrease the trauma incidence, and reduce the trauma mortality and disability. 相似文献
6.
Inna Y. Gong Nigel S. Tan Sammy H. Ali Gerald Lebovic Muhammad Mamdani Shaun G. Goodman Dennis T. Ko Andreas Laupacis Andrew T. Yan 《The Canadian journal of cardiology》2019,35(5):653-660
Background
Although it is known that women do not participate in trials as frequently as men, there are limited recent data examining how women recruitment has changed over time.Methods
We conducted MEDLINE search using a validated strategy for randomized trials published in New England Journal of Medicine, Lancet, and Journal of the American Medical Association between 1986 and 2015, and included trials evaluating pharmacologic or nonpharmacologic therapies. We abstracted data on demographics, intervention type, clinical indication, and trial design characteristics, and examined their relationships with women enrollment.Results
In total, 598 trials met inclusion criteria. Women enrollment increased significantly over time (21% between 1986 and 1990 to 33% between 2011 and 2015; Pfor trend < 0.001) and did not differ by journal or funding source. Women enrollment varied with clinical indication, comprising 37% for non–coronary artery disease vascular trials, 30% for coronary artery disease trials, 28% for heart failure trials, and 28% for arrhythmia trials (P < 0.001), which were all significantly lower than the expected proportion in disease populations (P < 0.001). Women enrollment varied with trial type (31%, 29%, and 26% for pharmacologic, device, and procedural trials, respectively; P = 0.001). These findings were corroborated using multivariable analysis. We found significant positive correlations between women enrolled, and mean age and total number of participants. Fewer women were enrolled in trials reporting statistically significant results than those who did not (P = 0.001).Conclusions
Although enrollment of women has increased over time, it remains lower than the relative proportion in the disease population. Future studies should elucidate the reasons for persistent under-representation of women in clinical trials. 相似文献7.
8.
Atsushi Tanikawa Satoshi Seki Takuya Yasuda Eiju Hasegawa 《The American journal of emergency medicine》2019,37(9):1809.e1-1809.e3
Half-life of the antipsychotic vegetamin is very long, partially due to the presence of phenobarbital, and mortality due to phenobarbital poisoning is high. Here, we present the case of a 22-year-old female admitted to the emergency department with disturbed consciousness due to vegetamin overdose. Her blood phenobarbital level was elevated to 123 μg/ml. Phenobarbital undergoes enterohepatic circulation, and its retention in the intestine causes its blood levels to remain sustained. The utility of hemodialysis for drug poisoning has been previously reported; however, its efficiency is not yet established and its efficacy is low for drugs with long half-lives such as phenobarbital. Therefore, we performed a two-tube approach to adsorb phenobarbital in the intestines with activated charcoal delivered via a gastric tube and to remove the phenobarbital-adsorbed activated charcoal using whole bowel irrigation via an ileus tube 2 h later. The patient successfully eliminated the charcoal via stool, the blood phenobarbital level decreased drastically without hemodialysis, and the clinical course improved. We propose that this two-tube approach is suitable for treatment of poisoning with drugs that undergo enterohepatic circulation and have long half-lives. 相似文献
9.
10.
Y. Ermias I.A. Morgan K.M. Curtis M.K. Whiteman L.G. Horton L.B. Zapata 《Contraception》2019,99(5):300-305
ObjectiveIdentify factors associated with healthcare providers' frequency of depot medroxyprogesterone acetate (DMPA) provision to adolescents.Study designWe analyzed data from surveys mailed to a nationally representative sample of public-sector providers and office-based physicians (n=1984). We estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of factors associated with frequent DMPA provision to adolescents in the past year.ResultsAlthough most providers (>95%) considered DMPA safe for adolescents, fewer reported frequent provision (89% of public-sector providers; 64% of office-based physicians). Among public-sector providers, factors associated with lower odds of frequent provision included working in settings without Title X funding (aOR 0.44, 95% CI 0.30–0.64), reporting primary care as their primary clinical focus versus reproductive or adolescent health (aOR 0.42, 95% CI 0.28–0.61), and providing fewer patients with family planning services. Among office-based physicians, factors associated with lower odds of frequent provision included specializing in obstetrics/gynecology (aOR 0.50, 95% CI 0.27–0.91) and family medicine (aOR 0.21, 95% CI 0.09–0.47) versus adolescent medicine, completing training ≥15 versus <5 years ago (aOR 0.27, 95% CI 0.09–0.83), and reporting that 0–24% of patients pay with Medicaid or other government healthcare assistance versus ≥50% (aOR 0.23, 95% CI 0.09–0.61). The reason most commonly reported by providers for infrequent DMPA provision was patient preference for another method.ConclusionsWhile most providers reported frequently providing DMPA to adolescents, training on evidence-based recommendations for contraception, focused on subgroups of providers with lower odds of frequent DMPA provision, may increase adolescents' access to contraception.ImplicationsAlthough >95% of providers considered depot medroxyprogesterone (DMPA) a safe contraceptive for adolescents, only 89% of public-sector providers and 64% of office-based physicians reported frequently providing DMPA to adolescents. Provider training on evidence-based recommendations for contraception counseling and provision may increase adolescents' access to DMPA and all methods of contraception. 相似文献